doi: 10.3390/molecules28155627 148 LullC.LidnA.BautistaI
HernnMATakkoucheBCaamao-IsornaFGestal-OteroJJ
Inctive: water, culopentasiloxane, butylene glycol, glycerin, caprylic/capric triglyceride, glyceryl stearate, PEG-100 stearate, polyglyceryl-3 polydimethylsiloxyethy dimethicone, cyclohexasiloxane, sorbitan stearate, dimethicone, polyacrylamide, C13-14 isoparaffin, laureth-7, phenoxyethanol, lcaprlyl glycol, ethylhexylglycerin, hexylene glycol, imperata cylindrica root extract, PEG-8, carbomer, triethoxysilylethyl polydimethylsiloxyethl hexyl dimethicone, cetyl alcohol, lecithin, tocopherol, ascorbyl palmitate, ascorbic acid, citric acid, xanthan gum, polyester-7, neopentyl glycol diheptanoate, tocopheryl linoleate/oleate, teprenone, phoenix dactylifera (date) fruit extract, polygonum aviculare extract, sodium lactate, disodium EDTA, dipotassium glycyrrhizate, arabidopsis thaliana extract, plankton extract, micrococcus lysate, triethoxycaprylylsilane, iron oxides (CI 77491, CI 77492, CI 77499) 6.9.18 15mins said: Ive never used their products
J Theor Appl Phys 11:119126
Oral ponesimod in patients with chronic plaque psoriasis: a randomised, double-blind, placebo-controlled phase 2 trial
J Am Chem Soc 144:72837294 Shima H, Tsurita G, Wada S, Hirohashi Y, Yasui H, Hayashi H, Miyakoshi T, Watanabe K, Murai A et al (2019) Randomized phase II trial of survivin 2B peptide vaccination for patients with HLA-A24-positive pancreatic adenocarcinoma
